Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 21, 2017 - Issue 3
Submit an article Journal homepage
611
Views
20
CrossRef citations to date
0
Altmetric
Review

Androgen receptor activation: a prospective therapeutic target for bladder cancer?

Taichi MizushimaDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA;Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USAView further author information
,
Kathleen A. TiradorDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USAView further author information
&
Hiroshi MiyamotoDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA;Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA;Department of Urology, University of Rochester Medical Center, Rochester, NY, USACorrespondence[email protected]
View further author information
Pages 249-257 | Received 11 Nov 2016, Accepted 06 Jan 2017, Published online: 19 Jan 2017

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Takuro Goto & Hiroshi Miyamoto. (2020) Why has the prognosis for muscle-invasive bladder cancer not significantly improved after decades of therapeutic advancements?. Expert Review of Anticancer Therapy 20:4, pages 229-231.
Read now

Articles from other publishers (19)

Zhifeng Liu, Yuxi Tian, Xin Zhang, Juncheng Wang & Jing Yang. (2022) Identification of a novel prognostic ADME-related signature associated with tumor immunity for aiding therapy in head and neck squamous cell carcinoma. Cancer Gene Therapy 30:5, pages 659-670.
Crossref
Kimberley D. Katleba, Maria-Malvina Tsamouri, Maitreyee Jathal, Han Bit Baek, Rebecca B. Armenta, Clifford G. Tepper, Gino Cortopassi, Paramita M. Ghosh & Maria Mudryj. (2023) Androgen receptor-dependent regulation of metabolism in high grade bladder cancer cells. Scientific Reports 13:1.
Crossref
Min Lin, Haiyan Zhu, Qi Shen, Lu-Zhe Sun & Xueqiong Zhu. (2022) GLI3 and androgen receptor are mutually dependent for their malignancy-promoting activity in ovarian and breast cancer cells. Cellular Signalling 92, pages 110278.
Crossref
Xue Li, Lihong Lu, Wenting Hou, Fei Wang, Ting Huang, Zhipeng Meng & Minmin Zhu. (2022) The SETD8/ELK1/bach1 complex regulates hyperglycaemia-mediated EndMT in diabetic nephropathy. Journal of Translational Medicine 20:1.
Crossref
Dong Gui Hu, Shashikanth Marri, Peter I. Mackenzie, Julie-Ann Hulin, Ross A. McKinnon & Robyn Meech. (2021) The Expression Profiles and Deregulation of UDP-Glycosyltransferase (UGT) Genes in Human Cancers and Their Association with Clinical Outcomes. Cancers 13:17, pages 4491.
Crossref
Hongyi Li, Yu Liu, Yang Wang, Xia Zhao & Xiaorong Qi. (2021) Hormone therapy for ovarian cancer: Emphasis on mechanisms and applications (Review). Oncology Reports 46:4.
Crossref
Michel D. Wissing, Ana O'Flaherty, Alice Dragomir, Simon Tanguay, Wassim Kassouf & Armen G. Aprikian. (2021) The Use of 5-Alpha Reductase Inhibitors and Alpha-1 Blockers Does Not Improve Clinical Outcome in Male Patients Undergoing Radical Cystectomy for Bladder Cancer in Quebec, Canada. Clinical Genitourinary Cancer 19:4, pages 371-371.e9.
Crossref
Eve Pellerin, Christophe Caneparo, Stéphane Chabaud, Stéphane Bolduc & Martin Pelletier. (2021) Endocrine-disrupting effects of bisphenols on urological cancers. Environmental Research 195, pages 110485.
Crossref
Dong Gui Hu, Peter I. Mackenzie, Pramod C. Nair, Ross A. McKinnon & Robyn Meech. (2020) The Expression Profiles of ADME Genes in Human Cancers and Their Associations with Clinical Outcomes. Cancers 12:11, pages 3369.
Crossref
Christina Santella, Julie Rouette, Michael D. Brundage, Kristian B. Filion & Laurent Azoulay. (2020) Androgen deprivation therapy for prostate cancer and the risk of bladder cancer: A systematic review of observational studies. Urologic Oncology: Seminars and Original Investigations 38:11, pages 816-825.
Crossref
Ana Raquel Costa, Mariana Lança de Oliveira, Inês Cruz, Isabel Gonçalves, José Francisco Cascalheira & Cecília R.A. Santos. (2020) The Sex Bias of Cancer. Trends in Endocrinology & Metabolism 31:10, pages 785-799.
Crossref
Taichi Mizushima, Guiyang Jiang, Takashi Kawahara, Peng Li, Bin Han, Satoshi Inoue, Hiroki Ide, Ikuma Kato, Mehrsa Jalalizadeh, Etsuko Miyagi, Mitsunori Fukuda, Leonardo O. Reis & Hiroshi Miyamoto. (2020) Androgen Receptor Signaling Reduces the Efficacy of Bacillus Calmette-Guérin Therapy for Bladder Cancer via Modulating Rab27b-Induced Exocytosis. Molecular Cancer Therapeutics 19:9, pages 1930-1942.
Crossref
Abdel Mouman Ghoumari, Charly Abi Ghanem, Narimène Asbelaoui, Michael Schumacher & Rashad Hussain. (2020) Roles of Progesterone, Testosterone and Their Nuclear Receptors in Central Nervous System Myelination and Remyelination. International Journal of Molecular Sciences 21:9, pages 3163.
Crossref
Herring, Elison & Tessem. (2019) Function of Nr4a Orphan Nuclear Receptors in Proliferation, Apoptosis and Fuel Utilization Across Tissues. Cells 8:11, pages 1373.
Crossref
Taichi Mizushima & Hiroshi Miyamoto. (2019) The Role of Androgen Receptor Signaling in Ovarian Cancer. Cells 8:2, pages 176.
Crossref
Philipp Erben, Danijel Sikic, Ralph M. Wirtz, Thomas Martini, Cleo-Aron Weis, Johannes Breyer, Wolfgang Otto, Bastian Keck, Arndt Hartmann & Christian Bolenz. (2018) Analysis of the prognostic relevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladder. Virchows Archiv 474:2, pages 209-217.
Crossref
Zhaofeng Lu, Zhuang Miao, Jian Zhu & Gangyi Zhu. (2018) ETS-domain containing protein (Elk1) suppression protects cortical neurons against oxygen-glucose deprivation injury. Experimental Cell Research 371:1, pages 42-49.
Crossref
Hiroki Ide, Satoshi Inoue, Taichi Mizushima, Guiyang Jiang, Kuang-Hsiang Chuang, Mototsugu Oya & Hiroshi Miyamoto. (2018) Androgen Receptor Signaling Reduces Radiosensitivity in Bladder Cancer. Molecular Cancer Therapeutics 17:7, pages 1566-1574.
Crossref
Satoshi Inoue, Taichi Mizushima, Kazutoshi Fujita, Abdelrazak Meliti, Hiroki Ide, Seiji Yamaguchi, Hiroaki Fushimi, George J. Netto, Norio Nonomura & Hiroshi Miyamoto. (2017) GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator. Human Pathology 64, pages 83-90.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.